Professor John Bell

Astrazeneca-Oxford Covid-19 vaccine lead Sir John Bell on approval process and clinical trials

CNBC Television

Sir John Bell - Short Version

Longevity Dividend

Helping British People Live Longer, Healthier Lives With Sir John Bell

Tony Blair Institute for Global Change

Covid becoming 'more efficient at living in humans', says University of Oxford's Prof Sir John Bell

"These vaccines are unlikely to "completely sterilize" a population. Professor Sir John Bell, SAGE!

Prix Galien UK 2024 Awards Ceremony - Professor Sir John Bell

The Galien Foundation

The Future of HealthTech with Professor Sir John Bell

Association of British HealthTech Industries

John Bell: The Changing Character of Comparative Law

Cambridge Law Faculty

The future for UK health I Professor Sir John Bell I RSA REPLAY

RSA

Pandemic Policy Summit 2023: Welcome from Professor Sir John Bell

Sir John Bell: South African variant of COVID is more worrying than the Kent one "by some margin"

Precision medicine and Oxford, challenges and opportunities - Sir John Bell GBE

Health Innovation Oxford

Sir John Bell: Pulse of the Industry Interview

Sir John Bell - Health, Ageing and Longevity Conference Apr 2022

Longevity Dividend

COVID-19: Are we close to herd immunity? | BBC Sounds

Rhodes Ahead: Prof Sir John Bell Interview

Sir John Bell - UK Biobank and the UK Life Science Industrial Strategy

Racing to Beat COVID-19: The Oxford Vaccine and Other Tales from the UK

The Rockefeller University

The Alumni Summit 2015 - Sir John Bell - Oxford AHSN

Health Innovation Oxford